Skip to main content
. 2017 Jul 5;2017(7):CD003414. doi: 10.1002/14651858.CD003414.pub3

Summary of findings 3. Natural cycle FET versus modified natural cycle FET (HCG trigger).

Natural cycle FET versus other regimens for primary or secondary subfertility
Population: subfertile women
 Settings: assisted reproductive technology clinics
 Intervention: natural cycle FET
 Comparison: natural cycle plus HCG trigger FET1
Outcomes Illustrative comparative risks* (95% CI) Relative effect
 (95% CI) No of participants
 (studies) Quality of the evidence
 (GRADE) Comments
Assumed risk Corresponding risk
Modified natural cycle FET (HCG trigger) Natural cycle FET
Live birth rate per woman 267 per 1000 167 per 1000 
 (55 to 413) OR 0.55 
 (0.16 to 1.93) 60
 (1 study) ⊕⊝⊝⊝
 Very low2,3 Only 13 events
Miscarriage rate per woman 24 per 1000 5 per 1000 
 (0 to 92) OR 0.20 
 (0.01 to 4.13) 168
 (1 study) ⊕⊝⊝⊝
 Very low2,4 Only 2 events
Ongoing pregnancy rate per woman 107 per 1000 226 per 1000 
 (110 to 408) OR 2.44 
 (1.03 to 5.76) 168
 (1 study) ⊕⊝⊝⊝
 Very low2,4 Only 28 events
Multiple pregnancy per woman No data available
*The basis for the assumed risk is the mean control group risk across studies. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
 CI: confidence interval; FET: frozen‐thawed embryo transfer; GnRHa: gonadotrophin releasing hormone agonist;HCG: human chorionic gonadotrophin; HT: hormone therapy; OR: odds ratio.
GRADE Working Group grades of evidenceHigh quality: We are very confident that the true effect lies close to that of the estimate of the effect
 Moderate quality: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different
 Low quality: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect
 Very low quality: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect

1One other study compared natural cycle FET versus natural cycle plus human menopausal gonadotrophin, but did not report any per‐woman data.
 2Downgraded two levels due to very serious imprecision: single study, few events, confidence interval compatible with benefit in the modified natural cycle only or with no effect.
 3Downgraded one level due to serious risk of bias: high attrition rate, baseline characteristics unequal.
 4Downgraded one level due to serious risk of bias: no allocation concealment.